Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Redeemable Convertible Preferred Stock Series B [Member]
Balance at the beginning at Dec. 31, 2020	$ 38,600	$ 40	$ 141,644	$ 17	$ (103,101)
Balance at the beginning (in Shares) at Dec. 31, 2020		40,372,133
Issuance of redeemable convertible preferred stock, net of issuance costs						$ 29,990
Issuance of redeemable convertible preferred stock, net of issuance costs (in Shares)						22,686,025
Retroactive application of recapitalization	29,990	$ 8	29,982
Retroactive application of recapitalization (in Shares)		7,706,861
Retroactive application of recapitalization						$ (29,990)
Retroactive application of recapitalization (in Shares)						(22,686,025)
Exercise of stock options	440	$ 1	439
Exercise of stock options, (in Shares)		304,080
Vesting of restricted common stock awards	2		2
Stock based compensation expense	950		950
Other comprehensive income (loss)	15			15
Net loss	(12,106)				(12,106)
Balance at the ending at Mar. 31, 2021	57,891	$ 49	173,017	32	(115,207)
Balance at the ending (in Shares) at Mar. 31, 2021		48,383,074
Balance at the beginning at Dec. 31, 2020	38,600	$ 40	141,644	17	(103,101)
Balance at the beginning (in Shares) at Dec. 31, 2020		40,372,133
Net loss	(16,599)
Balance at the ending at Jun. 30, 2021	54,891	$ 49	174,540	2	(119,700)
Balance at the ending (in Shares) at Jun. 30, 2021		48,593,822
Balance at the beginning at Mar. 31, 2021	57,891	$ 49	173,017	32	(115,207)
Balance at the beginning (in Shares) at Mar. 31, 2021		48,383,074
Exercise of stock options	324		324
Exercise of stock options, (in Shares)		210,748
Vesting of restricted common stock awards	3		3
Stock based compensation expense	1,196		1,196
Other comprehensive income (loss)	(30)			(30)
Net loss	(4,493)				(4,493)
Balance at the ending at Jun. 30, 2021	54,891	$ 49	174,540	2	(119,700)
Balance at the ending (in Shares) at Jun. 30, 2021		48,593,822
Balance at the beginning at Dec. 31, 2021	344,747	$ 88	506,760	(765)	(161,336)
Balance at the beginning (in Shares) at Dec. 31, 2021		87,598,184
Exercise of stock options	265		265
Exercise of stock options, (in Shares)		111,315
Stock based compensation expense	3,205		3,205
Business combination and PIPE financing, issuance costs	(8)		(8)
Other comprehensive income (loss)	(2,645)			(2,645)
Net loss	(25,208)				(25,208)
Balance at the ending at Mar. 31, 2022	320,356	$ 88	510,222	(3,410)	(186,544)
Balance at the ending (in Shares) at Mar. 31, 2022		87,709,499
Balance at the beginning at Dec. 31, 2021	$ 344,747	$ 88	506,760	(765)	(161,336)
Balance at the beginning (in Shares) at Dec. 31, 2021		87,598,184
Exercise of stock options, (in Shares)	357,212
Net loss	$ (50,066)
Balance at the ending at Jun. 30, 2022	298,704	$ 88	514,365	(4,347)	(211,402)
Balance at the ending (in Shares) at Jun. 30, 2022		87,997,949
Balance at the beginning at Mar. 31, 2022	320,356	$ 88	510,222	(3,410)	(186,544)
Balance at the beginning (in Shares) at Mar. 31, 2022		87,709,499
Issuance of common stock from exercise of options and employee stock purchase plan	718		718
Issuance of common stock from exercise of options and employee stock purchase plan (in Shares)		288,450
Stock based compensation expense	3,425		3,425
Other comprehensive income (loss)	(937)			(937)
Net loss	(24,858)				(24,858)
Balance at the ending at Jun. 30, 2022	$ 298,704	$ 88	$ 514,365	$ (4,347)	$ (211,402)
Balance at the ending (in Shares) at Jun. 30, 2022		87,997,949